BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Up 975.6% in July

BiomX Inc. (NYSEAMERICAN:PHGE) saw a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 2,020,000 shares, agrowthof975.6% from the June 30th total of 187,800 shares. Based on an average trading volume of 1,070,000 shares, the days-to-cover ratio is presently 1.9 days. Currently,14.9% of the company’s shares are short sold. Currently,14.9% of the company’s shares are short sold. Based on an average trading volume of 1,070,000 shares, the days-to-cover ratio is presently 1.9 days.

BiomX Stock Up 1.8%

Shares of BiomX stock opened at $0.40 on Monday. The stock’s fifty day simple moving average is $0.45. The company has a market capitalization of $10.38 million, a price-to-earnings ratio of -0.47 and a beta of 1.42. BiomX has a 12 month low of $0.34 and a 12 month high of $1.98.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright lowered their target price on BiomX from $21.00 to $15.00 and set a “buy” rating for the company in a report on Friday, May 16th.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).